AI assistant
Sending…
HEALTHEQUITY, INC. — Director's Dealing 2016
Apr 5, 2016
30722_dirs_2016-04-05_a92fe3c6-c333-4269-a8a8-eacb6be6bb51.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2016-04-01
Reporting Person: MOTT DARCY G (Executive VP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-01 | Common Stock | M | 42000 | $0.1 | Acquired | 80000 | Direct |
| 2016-04-01 | Common Stock | S | 30000 | $25 | Disposed | 50000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-01 | Stock Option (right to buy) | $0.1 | M | 42000 | Disposed | 2017-06-20 | Common Stock (42000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $14 | 2024-07-30 | Common Stock (10000) | 10000 | Direct |
| Stock Option (right to buy) | $0.1 | 2018-05-22 | Common Stock (20000) | 20000 | Direct |
| Stock Option (right to buy) | $1.25 | 2021-08-08 | Common Stock (125000) | 125000 | Direct |
| Stock Option (right to buy) | $25.39 | 2025-03-26 | Common Stock (25000) | 25000 | Direct |
Footnotes
F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.
F2: The option is immediately exercisable.
F3: The option becomes exercisable in four equal annual installments on March 26, 2016, 2017, 2018 and 2019.
More from HEALTHEQUITY, INC.
Interim / Quarterly Report
2026
May 28
Earnings Release
2026
May 28
Annual Report
2026
May 13
Board/Management Information
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Annual Report
2026
Mar 17